Eli Lilly Sees Strong Uptake of Mounjaro as India’s Obesity Market Poised for Rapid Growth
Eli Lilly has reported a warm reception for its obesity and diabetes therapy Mounjaro in India, underscoring both the urgent need for effective weight‑management solutions and the vast commercial potential of one of the world’s fastest‑growing markets for obesity drugs. Having outpaced competitors to bring the once‑weekly injectable to Indian patients earlier this year, Lilly…









